Mycophenolate vs Azathioprin in Autoimmune Hepatitis

NCT00687180 Phase 4 COMPLETED

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Details

Lead sponsor	Rigshospitalet, Denmark
Phase	Phase 4
Status	COMPLETED

Conditions

• Autoimmune Hepatitis

Interventions

• Treatment with mycophenolat mofetil
• Treatment with azathioprin

Countries

Denmark